Astrazeneca Pharma India Ltd Astrazeneca Pharma India Ltd Share Price Today – Live NSE/BSE Stock Price, Financials & Company Overview

Past performance
Performance overview
Astrazeneca Pharma India Ltd
About Astrazeneca Pharma India Ltd AstraZeneca Pharma India Limited (APIL), a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, is engaged in manufacturing, distributing, and marketing pharmaceuticals. Established in 1979, the company focuses on therapy areas including Oncology, Cardiovascular, Diabetes, and Respiratory. APIL has expanded its operations with initiatives like the establishment of a modern R&D center in Bangalore and strategic partnerships with companies like Dr. Reddy's Laboratories and Sun Pharma to co-promote key treatments such as Saxagliptin and Ticagrelor. APIL faced challenges with regulatory pricing controls and supply disruptions but responded with strategic product launches, such as Arimidex for breast cancer and Fasenra for severe asthma. The company has also streamlined its portfolio to align with AstraZeneca's global therapeutic focus, divesting certain non-core brands. APIL's consistent growth in key brands and successful introduction of innovative treatments underscore its robust market presence and commitment to advancing healthcare solutions in India.
Website astrazeneca.in
Founded 1979
Headquarters Bangalore